Literature DB >> 18176630

Glial S100B Positive Vacuoles In Purkinje Cells: Earliest Morphological Abnormality In SCA1 Transgenic Mice.

Parminder J S Vig1, Maripar E Lopez, Jinrong Wei, David R D'Souza, Sh Subramony, Jeffrey Henegar, Jonathan D Fratkin.   

Abstract

Spinocerebellar ataxia-1 (SCA1) is caused by the expansion of a polyglutamine repeat within the disease protein, ataxin-1. The overexpression of mutant ataxin-1 in SCA1 transgenic mice results in the formation of cytoplasmic vacuoles in Purkinje neurons (PKN) of the cerebellum. PKN are closely associated with neighboring Bergmann glia. To elucidate the role of Bergmann glia in SCA1 pathogenesis, cerebellar tissue from 7 days to 6 wks old SCA1 transgenic and wildtype mice were used. We observed that Bergmann glial S100B protein is localized to the cytoplasmic vacuoles in SCA1 PKN. These S100B positive cytoplasmic vacuoles began appearing much before the onset of behavioral abnormalities, and were negative for other glial and PKN marker proteins. Electron micrographs revealed that vacuoles have a double membrane. In the vacuoles, S100B colocalized with receptors of advanced glycation end-products (RAGE), and S100B co-immunoprecipated with cerebellar RAGE. In SCA1 PKN cultures, exogenous S100B protein interacted with the PKN membranes and was internalized. These data suggest that glial S100B though extrinsic to PKN is sequestered into cytoplasmic vacuoles in SCA1 mice at early postnatal ages. Further, S100B may be binding to RAGE on Purkinje cell membranes before these membranes are internalized.

Entities:  

Year:  2006        PMID: 18176630      PMCID: PMC2174790          DOI: 10.1901/jaba.2006.23-166

Source DB:  PubMed          Journal:  J Neurol Sci Turk        ISSN: 1302-1664


  39 in total

1.  Rapid desensitization of PC12 cells stimulated with high concentrations of extracellular S100.

Authors:  S Fulle; M A Mariggiò; S Belia; C Petrelli; P Ballarini; S Guarnieri; G Fanò
Journal:  Neuroscience       Date:  1999-03       Impact factor: 3.590

Review 2.  Cytodifferentiation of Bergmann glia and its relationship with Purkinje cells.

Authors:  Keiko Yamada; Masahiko Watanabe
Journal:  Anat Sci Int       Date:  2002-06       Impact factor: 1.741

3.  Splice variants of the receptor for advanced glycosylation end products (RAGE) in human brain.

Authors:  Qunxing Ding; Jeffrey N Keller
Journal:  Neurosci Lett       Date:  2005-01-03       Impact factor: 3.046

Review 4.  NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses.

Authors:  S Ghosh; M J May; E B Kopp
Journal:  Annu Rev Immunol       Date:  1998       Impact factor: 28.527

Review 5.  Glutamine repeats and neurodegeneration.

Authors:  H Y Zoghbi; H T Orr
Journal:  Annu Rev Neurosci       Date:  2000       Impact factor: 12.449

6.  Electrical synapses between Bergmann glial cells and Purkinje neurones in rat cerebellar slices.

Authors:  Pavel Pakhotin; Alexei Verkhratsky
Journal:  Mol Cell Neurosci       Date:  2005-01       Impact factor: 4.314

7.  Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE).

Authors:  Lana E Hanford; Jan J Enghild; Zuzana Valnickova; Steen V Petersen; Lisa M Schaefer; Todd M Schaefer; Todd A Reinhart; Tim D Oury
Journal:  J Biol Chem       Date:  2004-09-20       Impact factor: 5.157

8.  Astrocytosis and axonal proliferation in the hippocampus of S100b transgenic mice.

Authors:  R H Reeves; J Yao; M R Crowley; S Buck; X Zhang; P Yarowsky; J D Gearhart; D C Hilt
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

9.  SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat.

Authors:  E N Burright; H B Clark; A Servadio; T Matilla; R M Feddersen; W S Yunis; L A Duvick; H Y Zoghbi; H T Orr
Journal:  Cell       Date:  1995-09-22       Impact factor: 41.582

10.  Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.

Authors:  W S Griffin; L C Stanley; C Ling; L White; V MacLeod; L J Perrot; C L White; C Araoz
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

View more
  12 in total

1.  Suppression of calbindin-D28k expression exacerbates SCA1 phenotype in a disease mouse model.

Authors:  Parminder J S Vig; Jinrong Wei; Qingmei Shao; Maripar E Lopez; Rebecca Halperin; Jill Gerber
Journal:  Cerebellum       Date:  2012-09       Impact factor: 3.847

2.  The design and delivery of a thermally responsive peptide to inhibit S100B-mediated neurodegeneration.

Authors:  S M Hearst; L R Walker; Q Shao; M Lopez; D Raucher; P J S Vig
Journal:  Neuroscience       Date:  2011-09-17       Impact factor: 3.590

3.  Dopamine D2 receptor signaling modulates mutant ataxin-1 S776 phosphorylation and aggregation.

Authors:  Scoty M Hearst; Mariper E Lopez; Qingmei Shao; Yong Liu; Parminder J S Vig
Journal:  J Neurochem       Date:  2010-04-30       Impact factor: 5.372

4.  Knockdown of acid-sensing ion channel 1a (ASIC1a) suppresses disease phenotype in SCA1 mouse model.

Authors:  Parminder J S Vig; Scoty M Hearst; Qingmei Shao; Maripar E Lopez
Journal:  Cerebellum       Date:  2014-08       Impact factor: 3.847

5.  Cellular fusion for gene delivery to SCA1 affected Purkinje neurons.

Authors:  K Amy Chen; Pedro E Cruz; Derek J Lanuto; Terence R Flotte; David R Borchelt; Arun Srivastava; Jianyi Zhang; Dennis A Steindler; Tong Zheng
Journal:  Mol Cell Neurosci       Date:  2011-03-17       Impact factor: 4.314

6.  Glial S100B protein modulates mutant ataxin-1 aggregation and toxicity: TRTK12 peptide, a potential candidate for SCA1 therapy.

Authors:  Parminder J S Vig; Scoty Hearst; Qingmei Shao; Mariper E Lopez; Henry A Murphy; Eshan Safaya
Journal:  Cerebellum       Date:  2011-06       Impact factor: 3.847

7.  Bergmann glial S100B activates myo-inositol monophosphatase 1 and Co-localizes to purkinje cell vacuoles in SCA1 transgenic mice.

Authors:  Parminder J S Vig; Qingmei Shao; S H Subramony; Mariper E Lopez; Eshan Safaya
Journal:  Cerebellum       Date:  2009-07-11       Impact factor: 3.847

8.  Focused cerebellar laser light induced hyperthermia improves symptoms and pathology of polyglutamine disease SCA1 in a mouse model.

Authors:  Scoty M Hearst; Qingmei Shao; Mariper Lopez; Drazen Raucher; Parminder J S Vig
Journal:  Cerebellum       Date:  2014-10       Impact factor: 3.847

9.  Glial response to polyglutamine-mediated stress.

Authors:  Parminder J S Vig; Qingmei Shao; Maripar E Lopez
Journal:  Biosci Hypotheses       Date:  2009-01-01

10.  Abnormalities in synaptic dynamics during development in a mouse model of spinocerebellar ataxia type 1.

Authors:  Yusuke Hatanaka; Kei Watase; Keiji Wada; Yoshitaka Nagai
Journal:  Sci Rep       Date:  2015-11-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.